Regeneron (REGN) traded up 1.04 % during a 24 hours period ending at 10:57 AM Central Europe on Wednesday 28th. One Regeneron stock can currently be bought for about USD 816.1 on popular exchanges. Current supply of Regeneron stocks is 99.4 mn. Regeneron has a current market capitalization of USD 80.4 bn and approximately USD 592.6 mn worth of Regeneron was traded on exchanges in the last 24 hours. Since last month end, Regeneron has traded 8.49 % up. Simple moving average of last 200 days is at USD 736.14. The highest price of past 52 weeks was recorded at USD 859.34 on 09/03/2026. 52 weeks low was at USD 591.52 on 06/02/2026.
Here is how related stocks have performed in the past 24 hours:
Us (USB) traded up 0.07 % and now trades at USD 59.74. Us has a market capitalisation of USD 92.7 bn. Current price/earnings ratio for Us is 11.63. U.S. Bancorp has announced the pricing of two series of senior medium‑term notes under its 1933 registration. The first offering, due July 29 2036, carries a fixed interest rate of six percent per year and will be callable by the issuer on designated dates beginning in 2028. The second series, maturing July 29 2041, offers a slightly higher rate of 6.25 percent and can be redeemed by the issuer from 2029 onward. Both issuances are structured as unsecured, non‑insured fixed‑rate notes, with principal payable at maturity unless the notes are called earlier. Investors can purchase the notes in $1,000 denominations, and the issuers have indicated that the proceeds from each offering will be used for general corporate purposes.
Johnson Controls Internation (JCI) traded up 5.68 % and now trades at USD 155.88. Johnson Controls Internation has a market capitalisation of USD 91.9 bn. Johnson Controls Internation has a current price to earnings ratio of 41.86. Johnson Controls International plc reported its fiscal fourth‑quarter 2026 results on 27 October 2026, noting a 10 % rise in sales to approximately $7.1 billion and a 12 % increase in organic sales. Earnings per share were 1.60 USD on a GAAP basis and 1.66 USD on an adjusted basis. The company also recorded a 44 % jump in organic orders and a 43 % growth in backlog, which now stands near $23 billion. Management highlighted continued margin expansion across all business segments, driven by productivity gains and a strong demand mix, particularly in data‑center and applied HVAC & controls markets. For fiscal 2027, the company reiterated guidance of 11 %–12 % organic sales growth and adjusted earnings per share between 6.15 USD and 6.30 USD, with a free‑cash‑flow conversion target close to 95 %. The announcement followed a conference call that detailed the quarter’s performance and reaffirmed confidence in sustained customer demand.
Cadence Design Sys (CDNS) traded up 6.49 % and now trades at USD 343.08. Cadence Design Sys has a market capitalisation of USD 95.1 bn. Current price/earnings ratio for Cadence Design Sys is 65.38.
Marsh & Mclennan Cos (MRSH) traded down -2.08 % and now trades at USD 190.67. Current market capitalisation for Marsh & Mclennan Cos is USD 91.6 bn. Marsh & Mclennan Cos has a current price to earnings ratio of 23.23.
Waste Management (WM) traded down -2.16 % and now trades at USD 235.81. Current market capitalisation for Waste Management is USD 95.3 bn. Current price/earnings ratio for Waste Management is 34.01.
About Regeneron
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company based in Tarrytown, United States. The company specializes in discovering, developing, and commercializing pharmaceutical products for the treatment of serious medical conditions. As a part of the health care sector in the United States, Regeneron Pharmaceuticals primarily serves the biotechnology industry. The official website of the company is accessible under www.regeneron.com and its stock is traded on the Nasdaq stock exchange. The Initial Public Offering (IPO) of the company took place on April 2nd, 1991.